Navigation Links
MIGENIX Reports Third Quarter Fiscal Year 2008 Financial Results
Date:3/13/2008

next 90 days.
-------------------------------------------------------------------------

Selected Financial Highlights

BALANCE SHEETS January 31, April 30,

Unaudited - In Thousands of Canadian dollars 2008 2007

-------------------------------------------------------------------------

Assets

Cash and cash equivalents $1,864 $2,945

Short-term investments 6,063 12,365

Other current assets 1,335 1,245

-------------------------------------------------------------------------

Total current assets $9,262 $16,555

Long-term investments 1 1

Property & equipment 1,088 881

Intangible assets 1,006 1,671

Deferred transaction costs(1) - 473

-------------------------------------------------------------------------

Total assets $11,357 $19,581

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Liabilities and Shareholders' Equity

Accounts payable and accrued liabilities $2,124 $1,958

-------------------------------------------------------------------------

Total current liabilities $2,124 $1,958

Convertible royalty participation units(1) 5,705 4,847

Preferred shares - 115

-------------------------------------------------------------------------

Total liabilities
'/>"/>

SOURCE MIGENIX Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. MIGENIX Third Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
2. MIGENIX releases CEO message #22
3. MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study
4. MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results
5. MIGENIX Second Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
6. MIGENIX to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
7. MIGENIX Reports First Quarter Fiscal Year 2008 Financial Results
8. MIGENIX to Present Positive Celgosivir Viral Resistance Data at International HCV Meeting
9. MIGENIX First Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
10. Nventa Biopharmaceuticals Reports Full Year 2007 and Fourth Quarter Financial Results
11. Micromet, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... May 23, 2013 PuraMed BioScience ® ... marketer of over-the-counter (OTC) medicinal and healthcare products, ... on the company based on low market capitalization ... Non-Prescription, All Natural Product to Treat Migraine Headaches ... #1 Prescription Competitor , Currently Available Nationwide ...
(Date:5/23/2013)... 23, 2013 VG Energy, an agricultural ... DAK Renewable Research to conduct field trials using ... Energy is a majority owned subsidiary of VG ... VG Energy,s exclusively licensed compound LipidMax selectively inhibits ... in plants, possessing a wide variety of applications ...
(Date:5/23/2013)... 2013 On April 19th the ... to search for the growing antibiotic resistant bacteria that ... a year long study were released late last month ... meats, over previous years. For those suffering from bacteria ... antibiotic resistant bacteria in food, may eventually help breed ...
(Date:5/23/2013)... May 23, 2013 Pressure BioSciences, Inc. (OTCQB: ... Company will host a teleconference to discuss its First ... update. The teleconference information is provided below: ... Daylight Time (EDT) Dial-in: (800) 875-3456 (U.S.); ... (Int,l) Passcode: VS22823 For those unable to ...
Breaking Biology Technology:PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria 2Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update 2
... 28 Stryker Corporation (NYSE: SYK ) learned today ... has returned an indictment charging Stryker Biotech LLC and certain ... conspiracy to defraud the U.S. Food and Drug Administration (FDA), ... FDA. The Company disclosed in March of this year that ...
... The Center for Business Intelligence (CBI), a division of Advanstar ... panel on Regulatory Risks, Compliance and Validation at ... coming up November 2 - 3, 2009 at the Doubletree ... CDRH Division of Bioresearch Monitoring of the FDA , ...
... MINNEAPOLIS, Oct. 28 Techne Corporation,s (Nasdaq: TECH ... 30, 2009 decreased 6.4% to $26.8 million or $.72 ... per diluted share for the quarter ended September 30, ... due to foreign currency fluctuations, decreased consolidated net sales ...
Cached Biology Technology:Stryker Statement in Response to the Indictment of Its Biotech Division 2CBI Announces FDA Participation at Upcoming Forum on Clinical Trial Investigator Portals 2CBI Announces FDA Participation at Upcoming Forum on Clinical Trial Investigator Portals 3Techne Corporation Releases Unaudited First Quarter Results For Fiscal Year 2010 2Techne Corporation Releases Unaudited First Quarter Results For Fiscal Year 2010 3Techne Corporation Releases Unaudited First Quarter Results For Fiscal Year 2010 4Techne Corporation Releases Unaudited First Quarter Results For Fiscal Year 2010 5Techne Corporation Releases Unaudited First Quarter Results For Fiscal Year 2010 6
(Date:5/24/2013)... immune system to combat metastatic cancer , Cancer ... by the immune system. Stimulation of the immune system ... many factors that cause the immune system to ignore ... function to suppress the immune system response. In this ... researchers led by Ronald Levy at Stanford University found ...
(Date:5/24/2013)... against Alzheimer,s disease, scientists have focused among other factors ... After all, it is the accumulation of A-beta that causes ... point for the formation of A-beta is APP. Alessia Soldano ... the function of APPL the fruit-fly version of APP ... Alessia Soldano (VIB/KU Leuven): "We have discovered that APPL ensures ...
(Date:5/23/2013)... Pacific Northwest National Laboratory honored more than ... of intellectual property at PNNL,s annual Intellectual Property ... The Department of Energy national laboratory named materials ... his work developing battery materials that can store ... electrical grid, and reduce the time it takes ...
Breaking Biology News(10 mins):JCI early table of contents for May 24, 2013 2JCI early table of contents for May 24, 2013 3JCI early table of contents for May 24, 2013 4JCI early table of contents for May 24, 2013 5JCI early table of contents for May 24, 2013 6JCI early table of contents for May 24, 2013 7JCI early table of contents for May 24, 2013 8A new strategy required in the search for Alzheimer's drugs? 2PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace 2
... What would be your response to a radiological incident? How ... take care of us? How do we even know if we ... addressed at the 42nd Midyear Topical Meeting of the Health Physics ... San Antonio, Texas at the Henry B. Gonzales Convention Center. The ...
... that certain marginalized groups including the mentally ill, ... and Latinos fare worse than others in the ... fatalities. Now, a new study ... also experience greater terrorism-related fears and make more behavioral ...
... Newark, Delaware became the first electric utility in the ... power for the local electric grid. The ... to store energy and improve grid reliability. University of ... With the City of Newark,s approval, the UD team ...
Cached Biology News:42nd Mid-year Topical Meeting of the Health Physics Society 2Disabled and other vulnerable groups more susceptible to terrorism fears 2City of Newark first in nation using cars to power grid 2
WNV Core Antibody...
HSD17B3 Immunogen: HSD17B3 (NP_000188, 29 a.a. ~ 120 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Rad51, N-terminal...
Phospho-mu-Opioid Receptor (Ser375) Antibody...
Biology Products: